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In this issue of JOVR, Derakhshan and co-
authors1 describe the results of crosslinking 
for patients with early keratoconus. Collagen 
crosslinking is a recently described technique 
of corneal tissue strengthening using riboflavin 
as a photosensitizer and ultraviolet A (UVA) 
radiation to promote the formation of intra- and 
interfibrillar covalent bonds by photosensitized 
oxidation.2 To date, it is the only published 
intervention that may retard the progression 
of keratoconus. Collagen crosslinking has also 
been sequentially combined with other treatment 
modalities, namely intrastromal ring segments 
and photorefractive keratectomy, for treatment 
of keratoconus.3 Other possible indications 
include keratectasia following laser in situ 
keratomileusis (LASIK)4, infectious keratitis 
and bullous keratopathy5.  
In vitro studies on human and porcine 
corneas have shown a significant increase in 
corneal rigidity after crosslinking as indicated 
by an increase in Young’s modulus.6 This 
stiffening effect was found to be depth-
dependent, i.e. anterior corneal layers were 
stiffer corresponding to maximum crosslinking 
effect. The first in vivo controlled clinical 
study was performed by Wollensak et al7 and 
included 23 eyes with moderate or advanced 
progressive keratoconus. This study showed 
that crosslinking was effective in halting the 
progression of keratoconus over a period of 4 
years. The authors reported mean reduction 
of 2.01 D in maximum keratometry and 1.14 D 
in spherical equivalent. These initial results 
were later supported by other studies showing 
varying degrees of improvement in visual 
acuity and reduction in keratometry with a 
progressive trend in improvement depending 
on the duration of follow-up.8,9 Collagen 
crosslinking has also been found to be relatively 
safe. Wollensak et al7 reported no change in 
corneal and lens transparency, endothelial cell 
density, and intraocular pressure. Epithelial 
regeneration was completed normally within 4 
days, and restoration of corneal sensitivity and 
repopulation of the corneal stroma occurred 
by 6 months.10 Few complications have been 
described including corneal scarring and stromal 
haze which require a variable duration for 
resolution11, and infectious keratitis including 
bacterial12, acanthamoeba13 and herpetic14 
infections.
Derakhshan et al1 have published their 
observational study on the effect of crosslinking 
as primary treatment for patients with early 
keratoconus. Their study enrolled 22 patients 
and treated 31 eyes with mean follow-up 
of 6 months. Their results show significant 
improvement in uncorrected and best spectacle 
corrected visual acuity, and reduction in 
spherical equivalent and keratometric readings. 
These changes however, were less marked 
than previously published studies. Visual 
improvement in most patients began from 
the first month, slightly increased by the third 
month and remained stable until six months. 
No complications such as cataracts, raised 
intraocular pressure, or persistent epithelial 
defects were noted in this study. The effect 
of treatment appeared to be less as compared 
to previous studies which is likely due to a 
difference in treatment groups; previous studies 
enrolled patients with progressive keratoconus, 
while their study was performed on patients 
with early keratoconus. Even though the authors 
ascertained the penetration of riboflavin into the Editorial; Tan and Mehta
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anterior chamber, the procedure was performed 
with the epithelium on.
This study offers some interesting insights 
into the use of collagen crosslinking for patients 
with early keratoconus. It is not unusual that the 
effect of the procedure was not as pronounced 
as in patients with moderate / progressive 
disease. Nevertheless, 77% of treated patients 
demonstrated an improvement in keratometry. 
Whether the latter translated into the possibility 
of subsequent optical correction with contact 
lenses was not addressed in the paper. However 
if this is actually the case, crosslinking may 
be advocated for patients with early disease. 
Longer term follow up is required to ensure 
that the observed changes are sustained. The 
unresolved issue is identifying the most suitable 
candidates for such treatment. For this purpose, 
analysis of early biomechanical changes may 
be a more sensitive means than keratometric 
or visual acuity changes.
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